These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3175309)

  • 1. Statistical standards for protocols and protocol deviations.
    Lewis JA
    Recent Results Cancer Res; 1988; 111():27-33. PubMed ID: 3175309
    [No Abstract]   [Full Text] [Related]  

  • 2. Surveillance of protocol deviations in Japanese oncology registration trials: a single institute experience.
    Sasada S; Ushirozawa N; Kobayashi N; Fujiwara Y; Tamura K; Yamamoto N
    Invest New Drugs; 2017 Jun; 35(3):392-396. PubMed ID: 28150072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Registration of trials and protocols.
    Staessen JA; Bianchi G
    Lancet; 2003 Sep; 362(9389):1009-10. PubMed ID: 14522528
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials--time for a paradigm shift?
    Bradley C
    Diabet Med; 1988 Mar; 5(2):107-9. PubMed ID: 2964973
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trials of orphan medicines.
    Buckley BM
    Lancet; 2008 Jun; 371(9629):2051-5. PubMed ID: 18555919
    [No Abstract]   [Full Text] [Related]  

  • 6. Statistical properties and use of sequential methods in randomized clinical trials when the response criterion is censored.
    Bénichou J; Chastang C
    Recent Results Cancer Res; 1988; 111():207-15. PubMed ID: 3175307
    [No Abstract]   [Full Text] [Related]  

  • 7. SOP 03: Preparation and structure of trial protocols.
    Onkologie; 2003 Oct; 26 Suppl 6():11-4. PubMed ID: 23570179
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment by protocol: assessment of gains and losses.
    Scheurlen H
    Recent Results Cancer Res; 1988; 111():87-94. PubMed ID: 3051233
    [No Abstract]   [Full Text] [Related]  

  • 9. Standardization of chemotherapy protocol summaries.
    Ross B
    Can Oncol Nurs J; 2000; 10(2):88-9. PubMed ID: 11022443
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-trial networking in AML: a step forward rather than corner cutting.
    Büchner T; Döhner H; Ehninger G; Ganser A; Niederwieser D; Hasford J
    Leuk Res; 2004 Jun; 28(6):649-50. PubMed ID: 15120943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations and advantages of meta-analysis in clinical trials.
    Rockette HE; Redmond CK
    Recent Results Cancer Res; 1988; 111():99-104. PubMed ID: 3175314
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power with Bonferroni adjustments.
    Leon AC
    J Clin Psychiatry; 2004 Nov; 65(11):1511-4. PubMed ID: 15554764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis on the requirements for clinical trial protocol writing of external treatment of TCM such as tuina].
    Gao S; Wang J; Wang H
    Zhongguo Zhen Jiu; 2015 Jun; 35(6):613-6. PubMed ID: 26480571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy clinical trials in the human brain. Protocol development and review of current applications.
    Kaplitt MG
    Front Neurol Neurosci; 2009; 25():180-188. PubMed ID: 19478520
    [No Abstract]   [Full Text] [Related]  

  • 15. [From a statistical standpoint].
    Nakazato H; Sakamoto J
    Gan To Kagaku Ryoho; 1991 Jul; 18(9):1517-25. PubMed ID: 1830199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical inference for clinical trials with binary responses when there is a shift in patient population.
    Yang LY; Chi Y; Chow SC
    J Biopharm Stat; 2011 May; 21(3):437-52. PubMed ID: 21442518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion for protocol eligibility.
    Callum JL; Henry B; Lin Y
    N Engl J Med; 2010 Oct; 363(17):1681-2. PubMed ID: 20961259
    [No Abstract]   [Full Text] [Related]  

  • 18. The Ottawa Statement. International registration of protocol information and results from human trials of health related interventions.
    Fedorowicz Z; Al-Hajeri AA
    Saudi Med J; 2005 Dec; 26(12):1860-1. PubMed ID: 16380762
    [No Abstract]   [Full Text] [Related]  

  • 19. Intention to treat analysis versus per protocol analysis of trial data.
    Sedgwick P
    BMJ; 2015 Feb; 350():h681. PubMed ID: 25663096
    [No Abstract]   [Full Text] [Related]  

  • 20. Statistical pitfalls of personalized medicine.
    Senn S
    Nature; 2018 Nov; 563(7733):619-621. PubMed ID: 30482931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.